According to Pfizer, COVID-19 vaccine is 100% safe to be used by the children between the age of 12 and 15. In addition, the vaccine is considered to be effective to ward off any illness due to coronavirus also.
Dr. Buddy Creech from Vanderbilt University Medical Center, Nashville who is a pediatric expert has said “This is exactly the news that we hoped to hear”. Two doses of the vaccine must be given to the recipient with the minimum gap of three weeks. Pfizer vaccine has been already approved for the people above the age of 16 in case of an emergency use.
Now, the company has been planning to ask for an emergency use authorization for the teenager between 12 years and 15 years. It is hoped that the teenagers may able to use the vaccine from the beginning of next school year.
CEO of Pfizer, Albert Bourla has said “We share the urgency to expand the authorization of our vaccine to use in younger populations and are encouraged by the clinical trial data from adolescents between the ages of 12 and 15.”
Recently, findings from the clinical trials have been released through a news release. However, it has not been peer viewed yet.
Pfizer vaccine trials have been administered on more than 2200 teenagers from USA. Half of them have been given real shot while the other half has been given placebo. In case of adults, the trial has been conducted on 43,000 participants. 18 cases have been reported among the kids that have received the placebo shot in comparison to the kids with the real shot. Similar side effects to the adult have been noticed such as sore arm, headache and fatigue.
BioTech CEO Ugur Sahin who is partner of Pfizer has said “encouraging given the trends we have seen in recent weeks regarding the spread of the B.1.1.7” which is a new variant of coronavirus that is more transmissible.
Teens vaccinated during the trials have been found with the neutralizing antibodies that are required to fight with the coronavirus. It is quite similar to the older teens and also young adults.
Creech has also said “Will it be 100 percent efficacious in the real world? Who’s to say? But what we know is that when we move this vaccine down into teenagers, it behaves the exact same way that it does in adults, or even better.”
During phase 3 trial on the adult, it has been found that Pfizer is 95% effective in order to get rid of symptomatic illness. Later on, it has come down to 90% in the real world that is released by CDC.
Creech has said later on that he is looking for complete data from the trial. He has said “There may be subtle differences there that we really have to keep an eye on for children. If there are slightly higher rates of fever, or if there’s slightly higher rates of muscle or joint aches, that has a different meaning in children than in adults.”
Now, Pfizer has been conducting trials in the children from 6 months to 11 years.